45T-20744-68408 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-31
Dose 1 — Moderna
2021-05-29
Dose 2 — Moderna
2022-05-17
Registered in v-safe
2022-05-17
Dose 3 — Moderna
2022-05-17
Survey response — day 0, dose 3
MedDRA: Muscle spasms — Feeling: Fair · Site: Itching

Free text: Muscle cramps

MedDRA releases: 2024-11 · check-in free text available
2022-05-18
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-05-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache · Be unable to work or attend school

Adult check-in
2022-05-23
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache

Adult check-in
2022-05-27
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-11-15
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-05-19
Survey response — 12 months, dose 3
MedDRA: Hypertension, Weight increased — Feeling: Good · Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-31	Moderna	No
2	2021-05-29	Moderna	No
3	2022-05-17	Moderna	No

Free text

Release 11 — day 0, dose 3

2022-05-17

Systemic reaction (other): Muscle cramps

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Hypertension	·	·	✓
SD	Weight increased	·	·	✓
SRO	Muscle spasms	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release